Joseph M Sheridan

This inventor holds 7 USPTO granted patents and 5 published patent applications, plus 2 CIPO patents and 6 EPO patents. Top assignees: Evolva Sa, Electrophoretics Limited, International Flavors & Fragrances Inc.. Active years: 2017-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Joseph M Sheridan. Retrieved from https://idiyas.com/inventor/joseph-m-sheridan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7 (Patent Applications = 5)

% Patents Active = 85.7

CIPO Patents = 2

EPO Patents = 6 (Patent Applications = 8)

Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 22(Granted Patents)

Location History:

Cobham, GB (2017)
Hertfordshire, GB (2018)
Royston, GB (2019 - 2021)

Company Filing History:

Electrophoretics Limited

patents

2 out of 1,585

International Flavors & Fragrances Inc.

patents

where one patent can have more than one assignee

Years Active: 2017-2021

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11008592 - Compositions and methods for the biosynthesis of vanillin or vanillin beta-d-glucoside (2021-05-18),

2. 10815514 - Production of steviol glycosides in recombinant hosts (2020-10-27),

3. 10815230 - Casein kinase 1 delta inhibitor (2020-10-27),

4. 10208293 - Compositions and methods for the biosynthesis of vanillan or vanillin beta-D-glucoside (2019-02-19),

5. 10119154 - Anthocyanins with specific properties (2018-11-06),

6. 9789111 - Casein kinase 1δ (CK 1δ) inhibitors (2017-10-17),

7. 9763947 - Casein kinase 1delta (CK1delta) inhibitors (2017-09-19),

Title: Joseph M Sheridan: Innovator in Biosynthesis and Neurodegenerative Treatments

Introduction

Joseph M Sheridan is a notable inventor based in Royston, GB. He has made significant contributions to the fields of biosynthesis and neurodegenerative disorder treatments. With a total of seven patents to his name, Sheridan's work has the potential to impact various industries.

Latest Patents

Among his latest patents is a groundbreaking invention related to the biosynthesis of vanillin or vanillin beta-D-glucoside. This patent discloses recombinant microorganisms, plants, and plant cells engineered to express specific polypeptides and enzymes that facilitate the production of vanillin. Another significant patent is for a casein kinase 1 delta inhibitor, which provides a novel compound for therapeutic use in treating neurodegenerative disorders, particularly Alzheimer's disease.

Career Highlights

Throughout his career, Sheridan has worked with prominent companies such as Evolva SA and Electrophoretics Limited. His innovative approaches and research have positioned him as a key figure in his field.

Collaborations

Sheridan has collaborated with notable individuals, including Jonathan R Heal and William D O Hamilton. These partnerships have likely contributed to the advancement of his research and inventions.

Conclusion

Joseph M Sheridan's contributions to innovation in biosynthesis and neurodegenerative treatments highlight his importance as an inventor. His patents reflect a commitment to addressing significant challenges in health and industry.

Profile summary based on public USPTO records.